Evidence mapPaperPMID 41306497Full record

ReviewFrontiers in medicine2025

Mooren's ulcer: a multifactorial autoimmune peripheral ulcerative keratitis and current treatment protocols.

Shangkun Ou, Yujie Zhang, Yuchong Feng, Xueer Zheng, Yuan Lin, Liying Zhang, Su Zhao, Yu Su, Han Cai, Longqin Lin and 3 more

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Enhanced Imaging of Ocular Surface Lesions.Journal of clinical medicine · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shangkun Ou *Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Yujie Zhang *Xiamen Eye Center and Eye Institute of Xiamen University, School of Medicine, Xiamen, China.
Yuchong Feng *Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Fujian Engineering and Research Center of Eye Regenerative Medicine, School of Medicine, Xiamen University, Xiamen, China.
Xueer ZhengDepartment of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Yuan LinXiamen Eye Center and Eye Institute of Xiamen University, School of Medicine, Xiamen, China.
Liying ZhangDepartment of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Su ZhaoDepartment of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Yu SuFujian Provincial Key Laboratory of Ophthalmology and Visual Science, Fujian Engineering and Research Center of Eye Regenerative Medicine, School of Medicine, Xiamen University, Xiamen, China.
Han CaiFujian Provincial Key Laboratory of Ophthalmology and Visual Science, Fujian Engineering and Research Center of Eye Regenerative Medicine, School of Medicine, Xiamen University, Xiamen, China.
Longqin LinFujian Provincial Key Laboratory of Ophthalmology and Visual Science, Fujian Engineering and Research Center of Eye Regenerative Medicine, School of Medicine, Xiamen University, Xiamen, China.
Hao GuDepartment of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Huping WuXiamen Eye Center and Eye Institute of Xiamen University, School of Medicine, Xiamen, China.
Yiming WuXiamen Eye Center and Eye Institute of Xiamen University, School of Medicine, Xiamen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mooren's Ulcer (MU) is a rare, chronic, and painful form of autoimmune peripheral ulcerative keratitis (PUK), with an elusive etiology and a risk of corneal perforation and vision loss. Despite numerous proposed triggers, including parasitic infections, hepatitis C virus, ocular trauma, and surgery, the pathogenesis of MU remains unclear, and diagnosis continues to rely heavily on exclusion. A key controversy in current clinical practice lies in the absence of standardized diagnostic criteria and consensus treatment protocols. This review addresses this gap by presenting a comprehensive and structured diagnostic framework for MU, particularly emphasizing laboratory and immunological testing strategies to facilitate accurate differential diagnosis. To our knowledge, this is the first review to systematize these diagnostic components in detail. In addition to summarizing the latest findings on epidemiology, etiology, pathology, and classification, the work also review the evolving role of advanced imaging, histopathology, and tear-based markers in MU diagnosis and monitoring. Treatment options, ranging from immunosuppressive therapy to surgical intervention, are discussed based on disease severity. This work recommend a tiered, individualized approach to treatment and advocate for future multicenter studies to validate diagnostic protocols and establish evidence-based clinical guidelines.

Indexed as

autoimmune corneal diseasescorneal meltfilarial nematodeshepatitis CHLAhookwormMooren’s ulcerperipheral ulcerative keratitis

Identifiers

PMID41306497
PMCPMC12643991

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.